Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-02-06

FDA Approved: KETOROLAC TROMETHAMINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ketorolac tromethamine from Teva Pharmaceuticals USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Toradol (ketorolac tromethamine)

Snippet

SUPPL AP for KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)